Dermatology Search
Dermatology Dermatology
atopic%20dermatitis
ATOPIC DERMATITIS
Atopic dermatitis or atopic eczema is a chronic, relapsing, familial, symmetric and pruritic inflammatory skin disease that commonly presents during early infancy and childhood, but can persist or start in adulthood.
It is commonly associated with elevated serum immunoglobulin E levels and a personal or family history of allergies, allergic rhinitis and asthma.
It is one of the most common skin diseases afflicting both children and adults.

Atopic Dermatitis References

  1. Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006 Jul;118(1):152-169. doi: 10.1016/j.jaci.2006.03.045. PMID: 16815151
  2. Barnetson R, Rogers M. Childhood atopic eczema. BMJ. 2002 Jun;324(7350):1376-1379. PMID: 12052810
  3. Beltrani VS. Clinical features of atopic dermatitis. Immunol Allergy Clin North Am. 2002 Feb;22(1):25-42
  4. Boguniewicz M, Nicol N. Conventional therapy for atopic dermatitis. Immunol Allergy Clin North Am. 2002 Feb;22:107-124
  5. Charman C. Clinical evidence: atopic eczema. BMJ. 1999 Jun;318(7198):1600-1604. PMID: 10364122
  6. Buys LM. Treatment options for atopic dermatitis. Am Fam Physician. 2007 Feb;75(4):523-528. http://www.aafp.org/. PMID: 17323714
  7. Correale CE, Walker C, Murphy L, et al. Atopic dermatitis: a review of diagnosis and treatment. Am Fam Physician. 1999 Sep;60(4):1191-1210. PMID: 10507748
  8. Christophers E, Folster-Holst R. Atopic dermatitis versus infantile eczema. J Am Acad Dermatol. 2001 Jul;45(1)(Suppl 1):S2-S3. PMID: 11423861
  9. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology Association. J Am Acad Dermatol. 1996 Oct;35(4):615-619. http://www.ncbi.nlm.nih.gov/pubmed. PMID: 8859293
  10. Eichenfield LF, Beck L. Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for the treatment of atopic dermatitis. J Allergy Clin Immunol. 2003 May;111(5):1153-1168. PMID: 12743593
  11. Ellis C, Luger T, Abeck D, et al. International consensus conference on atopic dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol. 2003 May;148(Suppl Suppl 63):3-10. doi: 10.1046/j.1365-2133.148.s63.1.x. PMID: 12694268
  12. Francisco RR. Atopic dermatitis in children. Skin forum: the newsletter in dermatology. 2007(19):5-8
  13. Gelbard CM, Hebert AA. New and emerging trends in the treatment of atopic dermatitis. Patient Prefer Adherence. 2008 Feb:387-392. Accessed 09 Nov 2011. PMID: 19920986
  14. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis. J Am Acad Dermatol. 2004 Mar;50(3):391-404. doi: 10.1016/j.jaad.2003.08.003. PMID: 14988682
  15. Hanifin JM, Rajka G. Diagnostic features of atopic eczema. Acta Dermatol Venereol (Stockh). 1980;92:44-47
  16. Kang S, Lucky AW, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol. 2001 Jan;44(Suppl 1):S58-S64. PMID: 11145796
  17. Ho VC, Gupta A, Kaufmann R, et al. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr. 2003 Feb;142(2):155-162. PMID: 12584537
  18. Knoell KA, Greer KE. Atopic dermatitis. Pediatr Rev. 1999 Feb;20(2):46-51. PMID: 9989110
  19. Kristal L, Klein PA. Atopic dermatitis in infants and children. An update. Pediatr Clin North Am. 2000 Aug;47(4):877-895. PMID: 10943263
  20. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003 Jan;361(9352):151-160. PMID: 12531593
  21. Leung DY, Niklas RA, Li JT, et al. Disease management of atopic dermatitis: an updated practice parameter. Ann Allergy Asthma Immunol. 2004 Sep;93(3)(Suppl 2):S1-S21. http://www.ncbi.nlm.nih.gov/pubmed/?term=15478395. PMID: 15478395
  22. Ong PY, Boguniewicz M. Atopic dermatitis. Prim Care Clin Office Pract. 2008 Mar;35(1):105-117. PMID: 18206720
  23. Reitamo S, Van Leent EJ, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol. 2002 Mar;109(3):539-546. PMID: 11898004
  24. Riccioni G, Di Ilio C, Conti P, et al. Advances in therapy with antileukotriene drugs. Ann Clin Lab Sci. 2004;34(4):379-387. Accessed 09 Nov 2011. PMID: 15648777
  25. Ring J, Alomar A, Bieber T, et al; European Dermatology Forum (EDF); European Academy of Dermatology and Venereology (EADV); European Federation of Allergy (EFA); European Task Force on Atopic Dermatitis (ETFAD); European Society of Pediatric Dermatology (ESPD); Global Allergy and Asthma European Network (GA2LEN). Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012 Aug;26(8):1045-1060. doi: 10.1111/j.1468-3083.2012.04635.x. Accessed 16 Jul 2013. PMID: 22805051
  26. Ring J, Alomar A, Bieber T, et al; European Dermatology Forum; European Academy of Dermatology and Venereology; European Task Force on Atopic Dermatitis; European Federation of Allergy; European Society of Pediatric Dermatology; Global Allergy and Asthma European Network. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. Jul 19, 2012. J Eur Acad Dermatol Venereol. 2012 Sep;26(9):1176-1193. doi: 10.1111/j.1468-3083.2012.04636.x. Accessed 16 Jul 2013. PMID: 22813359
  27. Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet. 1998 Jun;351(9117):1715-1721. http://www.ncbi.nlm.nih.gov/pubmed/?term=Rudikoff+D%2C+Lebwohl%09+Atopic+dermatitis. PMID: 9734903
  28. Rubel D, Thirumoorthy T, Soebaryo RW, et al; Asia-Pacific Consensus Group for Atopic Dermatitis. Consensus guidelines for the management of atopic dermatitis: an Asia- Pacific perspective. J Dermatol. 2013;40(3):160-171. doi: 10.1111/1346-8138.12065. PMID: 23289827
  29. Thomas KS, Armstrong S, Avery A, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ. 2002 Mar;324(7340):768. PMID: 11923161
  30. Thiele JJ, Ekanayake-Mudiyanselage S. Vitamin E in human skin: organ-specific physiology and considerations for its use in dermatology. Mol Aspects Med. 2007 Oct;28(5-6):646-667. doi: 10.1016/j.mam.2007.06.001. PMID: 17719081
  31. Wasserbauer N, Ballow M. Atopic dermatitis. Am J Med. 2009 Feb;122(2):121-125. doi: 10.1016/j.amjmed.2008.09.014. PMID: 19185084
  32. Williams HC, Burney PG, Pembroke AC, et al. The UK Working Party’s diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol. 1994 Sep;131(3):406-416. PMID: 7918017
  33. Habif TP. Clinical dermatology: a color guide to diagnosis and therapy. 4th ed. Pennsylvania: Mosby, Elsevier; 2004
  34. Chamlin SL. Atopic dermatitis. In: Rakel RE, Bope ET. Conn's Current Therapy. 60th ed. Philadelphia: Saunders, an imprint of Elsevier; 2008
  35. Lo KK, Chong LY, Tang YM. Handbook of dermatology & venereology: social hygiene handbook. 2nd ed. Western District, Hong Kong: Hygiene Service, Dept of Health; 1997
  36. Ferri FF. Atopic dermatitis. Ferri’s clinical advisor: instant diagnosis and treatment. 1st. Philadelphia, PA: Mosby, Elsevier; 2008.
  37. Boguniewicz M, Leung DY. Atopic dermatitis. In: Adkinson NF, Bochner BS, Busse WW, et al. Middleton's allergy principles & practice. 7th ed. Philadelphia: Mosby, Elsevier; 2008
  38. Shaw JC. Dermatitis and eczema. In: Noble J, Greene HL, Levinson W, et al. Textbook of primary care medicine. 3rd ed. Philadelphia: Mosby, Inc; 2001
  39. Leung DYM. Atopic Dermatitis (Atopic eczema). In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 21st. Philadelphia, PA: Elsevier Inc; 2020.
  40. MedWormhttp://www.medworm.com/rss/index.php/Allergy-%26-Immunology/3/http://www.medworm.com/rss/medicalfeeds/specialities/Allergy-Immunology.xml
  41. MedWorm http://www.medworm.com/rss/index.php/Dermatology/12/ http://www.medworm.com/rss/medicalfeeds/specialities/Dermatology-News.xml
  42. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  43. National Institute for Health and Care Excellence. Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years. NICE. http://www.nice.org.uk/. Dec 2007. Accessed 16 Jul 2013.
  44. Krafchik BR. Atopic dermatitis. eMedicine. http://www.emedicine.com/. Accessed 07 Apr 2006.
  45. Scottish Intercollegiate Guidelines Network. Management of atopic eczema in primary care. A national clinical guideline. SIGN. http://www.guideline.gov. Mar 2011.
  46. Kircik LH. Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study. J Drugs Dermatol. 2012 Jul;11(7):858-860. http://www.ncbi.nlm.nih.gov/pubmed/22777229. PMID: 22777229
  47. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014 Feb;70(2):338-351. doi: 10.1016/j.jaad.2013.10.010. Accessed 31 Aug 2016. PMID: 24290431
  48. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014 Jul;71(1):116-132. doi: 10.1016/j.jaad.2014.03.023. Accessed 31 Aug 2016. PMID: 24813302
  49. Fukami H, Tachimoto H, Kishi M, et al. Preparation of (13) C-labeled ceramide by acetic acid bacteria and its incorporation in mice. J Lipid Res. 2010 Nov;51(Suppl 11):3389-3395. doi: 10.1194/ jlr.D009191. PMID: 20656918
  50. Hon KL, Pong NH, Wang SS, Lee VW, Luk NM, Leung TF. Acceptability and efficacy of an emollient containing ceramide- precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients. Drugs R D. 2013 Mar(13)(Suppl 1):37-42. http://www.ncbi.nlm.nih.gov. Accessed 01 Apr 2015. PMID: 23456759
  51. Lio PA, Lee M, LeBovidge J, Timmons KG, Schneider L. Clinical management of atopic dermatitis: practical highlights and updates from the atopic dermatitis practice parameter 2012. J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):361-9;quiz 370. doi: 10.1016/j.jaip.2014.02.015. Accessed 15 Sep 2014. PMID: 25017522
  52. Schneider L, Tilles S, Lio P, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013 Feb;131(2):295-9.e1-27. https://www.aaaai.org. Accessed 15 Sep 2014. PMID: 23374261
  53. Chan AWM, Chan JKC, Lee TH, et al. Guidelines for allergy prevention in Hong Kong. Hong Kong Institute of Allergy. http://www.allergy.org.hk. Sep 2015. Accessed 07 Apr 2020.
  54. Leung TN, Hon KL. Eczema therapeutics in children: what do the clinical trials say. Hong Kong Med J. 2015 Jun;21(3):251-260. doi: 10.12809/hkmj144474. PMID: 25904389
  55. Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014 Aug;71(2):327-349. doi: 10.1016/j.jaad.2014.03.030. Accessed 19 Oct 2016. PMID: 24813298
  56. Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014 Dec;71(6):1218-1233. doi: 10.1016/j.jaad.2014.08.038. PMID: 25264237
  57. Galli E, Neri I, Ricci G, et al. Consensus conference on clinical management of pediatric atopic dermatitis. Ital J Pediatr. 2016 Mar;42:26. doi: 10.1186/s13052-016-0229-8. PMID: 26936273
  58. Wollenberg A, Oranje A, Deleuran M, et al; European Task Force on Atopic Dermatitis/EADV Eczema Task Force. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol. 2016 May;30(5):729-747. doi: 10.1111/jdv.13599. PMID: 27004560
  59. Eichenfield LF, Ahluwalia J, Waldman A, et al. Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol. 2017 Apr;139(45):S49-S57. doi: 10.1016/j.jaci.2017.01.009. PMID: 28390477
  60. van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM. Emollients and moisturisers for eczema. Cochrane Database Syst Rev. 2017 Feb;2(Suppl CD012119). doi: 10.1002/14651858.CD012119.pub2. PMID: 28166390
  61. Del Rosso J. Moisturizer and barrier repair formulations. In: Draelos Z, Dover J, Alam M. Cosmeceuticals. Third Edition: Elsevier; 2016. http://www.clinicalkey.com. Accessed 02 May 2018:81-89.
  62. Draelos Z. Cosmetics and Cosmeceuticals. In: Bolognia J, Schaffer J, Cerroni L. Dermatology. Fourth Edition; 2018. http://dx.doi.org/10.1016/B978-0-7020-6275-9.00153-7. :2578-2592.
  63. McAleer M A, O'Regan G M, Irvine A D. Atopic Dermatitis. In: Bolognia J, Schaffer J, Cerroni L. Dermatology. Fourth Edition. Philadelphia, PA; 2018. http://dx.doi.org/10.1016/B978-0-7020-6275-9.00012-X. :208-227.
  64. Wollenberg A, Barbarot S, Bieber T, et al; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018 May;32(5):657-682. doi: 10.1111/jdv.14891. PMID: 29676534
  65. Weston WL, Howe W. Treatment of atopic dermatitis (eczema). UptoDate. https://www.uptodate.com/. Dec 2018.
  66. Sidbury R, Kodama S. Atopic dermatitis guidelines: Diagnosis, systemic therapy, and adjunctive care. Clin Dermatol. 2018 Sep-Oct;36(5):648-652. doi: 10.1016/j.clindermatol.2018.05.008. PMID: 30217277
  67. Kasperkiewicz M, Mook SC, Knuth-Rehr D, et al. IgE-selective immunoadsorption for severe atopic dermatitis. Front Med (Lausanne). 2018 Feb;5:27. doi: 10.3389/fmed.2018.00027. PMID: 29484297
  68. Ministry of Health Malaysia. Clinical practice guideline: Management of atopic eczema. Ministry of Health Malaysia. http://www.moh.gov.my/. 2018.
  69. Wegner J, Saloga J, Grabbe S, et al. IgE-specific immunoadsorption: New treatment option for severe refractory atopic dermatitis. Allergy. 2019 Jun;74(6):1190-1193. doi: 10.1111/all.13716. PMID: 30636038
  70. Wollenberg A, Barbarot S, Bieber T,et al; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018 Jun;32(6):850-878. doi: 10.1111/jdv.14888. PMID: 29878606
Editor's Recommendations
Most Read Articles
Product Highlight - ADACEL
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Spotlight on multidrug-resistant gram-negative infections: New developments for an old problem
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
New asthma guide: What doctors should know
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Early life exposure helps ward off later allergies to cow’s milk formula
Yesterday
Daily intake of cow’s milk formula in early life helps prevent the development of cow’s milk allergy later on without competing with breastfeeding, a recent study has found.